Current & Prospective Peptide Users - FDA Compounding Policy

Article about FDA's peptide policy I’m a science journalist working on a story about the FDA's possible move to allow pharmacies to compound peptides that are currently on the agency's do-not-compound list. I'm curious to hear more about how this will affect people who a) currently use some of these peptides or b) are considering using them. If you’re open to a short phone or Zoom conversation, please email me at sktalpos at gmail dot com. You can read more about me and see some of my work here: saratalpos.com. Thank you!